REVLIMID® (lenalidomide) logo

This site is intended for US audiences only.

This site is intended for US audiences only.

REVLIMID® (lenalidomide) is a prescription medicine, used to treat adults with multiple myeloma (MM) in combination with the medicine dexamethasone, or as maintenance treatment after autologous hematopoietic stem cell transplantation (a type of stem cell transplant that uses your own stem cells). REVLIMID should not be used to treat people who have chronic lymphocytic leukemia (CLL) unless they are participants in a controlled clinical trial. It is not known if REVLIMID is safe and effective in children.

Back to Top

The REMS Companion App

Easily access the
Lenalidomide REMS program.

Download now

Access & Financial Resources

Tiffany, a REVLIMID® (lenalidomide) patient with multiple myeloma, and her husband holding their foreheads together while smiling

Patient Access, Reimbursement, and Co-Pay Support